Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial

Adjuvant radiotherapy reduces the risk of biochemical progression in prostate cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early salvage radiotherapy after radical prostatectomy, combined with short-term hormonal therapy, in terms of oncological outcomes and toler...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The lancet oncology 2020-10, Vol.21 (10), p.1341-1352
Hauptverfasser:	Sargos, Paul, Chabaud, Sylvie, Latorzeff, Igor, Magné, Nicolas, Benyoucef, Ahmed, Supiot, Stéphane, Pasquier, David, Abdiche, Menouar Samir, Gilliot, Olivier, Graff-Cailleaud, Pierre, Silva, Marlon, Bergerot, Philippe, Baumann, Pierre, Belkacemi, Yazid, Azria, David, Brihoum, Meryem, Soulié, Michel, Richaud, Pierre
Format:	Artikel
Sprache:	eng
Schlagworte:	Activities of daily living Adenocarcinoma Adenocarcinoma - drug therapy Adenocarcinoma - pathology Adenocarcinoma - radiotherapy Adenocarcinoma - surgery Aged Androgen Antagonists - administration & dosage Androgens Cancer surgery Disease Progression Dissection Erectile dysfunction France Humans Life Sciences Lymph nodes Lymphatic system Male Male Urogenital Diseases - epidemiology Male Urogenital Diseases - etiology Medical Overuse - prevention & control Metastasis Middle Aged Oncology Pathology Patients Prostate cancer Prostatectomy Prostatic Neoplasms - drug therapy Prostatic Neoplasms - pathology Prostatic Neoplasms - radiotherapy Prostatic Neoplasms - surgery Questionnaires Radiation therapy Radiotherapy, Adjuvant - adverse effects Salvage Therapy - adverse effects Survival Survival Analysis Toxicity Treatment Outcome Urological surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!